[Video] EndoPredict helps avoid Chemotherapy in Breast Cancer
In early stage breast cancers most patients do not benefit from undergoing chemotherapy therefore it may be safe for them to avoid chemotherapy. Using chemotherapy can create a host of unwanted health hazards.
Possible to avoid chemotherapy?
Yes but it depends on each individual case. The question for patients and doctors is how to segregate which patients will benefit and which patients will have no benefit. The EndoPredict test from Myriad Genetics is designed specially to answer these questions. EndoPredict is recommended by nearly all leading international guidelines including NCCN (USA), ASCO (USA), ESMO (Europe), and St. Galleon (Europe). Myriad Genetics (USA, founded 1991), is globally recognized for founding BRCA testing and continuing to be the gold standard for BRCA testing.
Read more on EndoPredict data on Indian patients published in leading international conferences.
Patient Video 1
EndoPredict allows patients of breast cancer in India to answer 3 important questions that can alter the course of treatment.
- What is my risk of this cancer returning within 10 years?
- Can I consider safely forgoing chemotherapy?
- Will I still need hormone therapy after 5 years?
These simple yet vital questions will allow you and your doctor to decide whether you can safely avoid chemotherapy.
![[Video] EndoPredict helps avoid Chemotherapy in Breast Cancer](https://davpzco6k33zaqxrn32z9ki5-wpengine.netdna-ssl.com/wp-content/blogs.dir/16/files/2018/12/EndoPredict-at-SABCS.gif "[Video] EndoPredict helps avoid Chemotherapy in Breast Cancer")
Blogs that might interest you:
